Acetylcholine and chronic vasculopathy in rat renal allografts

Transplantation

Volumn 91, Issue 3, 2011, Pages 263-270

  Wilczynska, Joanna ^a   Pfeil, Uwe ^a   Zakrzewicz, Anna ^a   Dietrich, Hartmut ^a   Körner, Christian ^a   Hecker, Andreas ^a   Wessler, Ignaz ^b   Padberg, Winfried ^a   Kummer, Wolfgang ^a   Grau, Veronika ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acetylcholine; Allograft vasculopathy; Cholinesterase inhibitor; Chronic rejection

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEIN; CHOLINE ACETYLTRANSFERASE; CHOLINE TRANSPORTER 1; MESSENGER RNA; PLACEBO; RIVASTIGMINE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CHRONIC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYMATIC DEGRADATION; ISOGRAFT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL GRAFT DYSFUNCTION; VASCULAR DISEASE;

ACETYLCHOLINE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTES; NERVE TISSUE PROTEINS; PHENYLCARBAMATES; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; RATS; RATS, INBRED F344; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 79951516338     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182038654     Document Type: Article

References (52)

1. Joosten SA, van Kooten C, Paul LC. Pathogenesis of chronic allograft rejection. Transpl Int 2003; 16: 137.
2. Chapman JR. Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations. Kidney Int 2006; 68: S108.
3. Nankivell B, Chapman JR. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643.
4. Serón D, Fulladosa X, Moresco F. Risk factors associated with the deterioration of renal function after kidney transplantation. Kidney Int Suppl 2005: S113.
5. Aita K, Yamaguchi Y, Horita S, et al. Peritubular capillaritis in early renal allograft is associated with the development of chronic rejection and chronic allograft nephropathy. Clin Transplant 2005; 19: 20.
6. Marco ML. The Fischer-Lewis model of chronic allograft rejection-A summary. Nephrol Dial Transplant 2006; 21: 3082.
7. WhiteE, Hildemann WH, Mullen Y. Chronic kidney allograft reactions in rats. Transplantation 1969; 8: 602.
8. Beckmann N, Cannet E, Fringeli-Tanner M, et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 2003; 49: 459.
9. Adriambeloson E, Cannet C, Pally C, et al. Transplantation-induced functional/morphological changes in rat aorta allografts differ from those in arteries of rat kidney allografts. Am J Transplant 2003; 4: 188.
10. Bedke J, Kiss E, Schaefer L, et al. Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant 2007; 7: 527.
11. Holler J, Zakrzewicz A, Kaufmann A, et al. Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. J Immunol 2008; 181: 6906.
12. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998; 10: 525.
13. Grau V, Stehling O, Garn H, et al. Accumulating monocytes in the vasculature of rat renal allografts: Phenotype, cytokine, iNOS, and tissue factor mRNA expression. Transplantation 2001; 71: 37.
14. Stehling O, Grau V, Celik I, et al. Monocyte cytotoxicity during acute kidney graft rejection in rats. IntImmunol 2004; 16: 101.
15. Vos IH, Briscoe DM. Endothelial injury: Cause and effect of alloim-mune inflammation. Transpl Infect Dis 2002; 4: 152.
16. Reinders MEJ, Rabelink TJ, Briscoe DM. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 2006; 17: 932.
17. Cailhier J-F, Laplante P, Hebert M-J. Endothelial apoptosis and chronic transplant vasculopathy: Recent results, novel mechanisms. Am J Transplant 2006; 6: 247.
18. Al-Lamki RS, Bradley JR, Pober JS. Endothelial cells in allograft rejection. Transplantation 2008; 86: 1340.
19. Hecker A, Lips KS, Pfeil U, et al. Pivotal advance: Upregulation of acetylcholine synthesis in intravascular transplant leukocytes during rejection of rat renal allografts. JLeukocBiol 2009; 86: 13.
20. Ignarro LJ, Buga GM, Byrns RE, et al. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacological properties as relaxants of bovine arterial and venous smooth muscle. J Pharmacol Exp Ther 1988; 246: 218.
21. Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: Implications in tobacco-related vascular diseases. Pharmacol Ther2009; 121: 205.
22. Saeed RW, Varma S, Peng-Nemeroff T, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201: 1113.
23. Patton GW, Powell DA, Hakki A, et al. Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells. Int Immunopharmacol 2006; 6: 26.
24. Cirillo P, De Rosa S, Pacileo M, et al. Nicotine induces tissue factor expression in cultured endothelial and smooth muscle cells. J Thromb Haemost 2006; 4: 453.
25. Aicher A, Heeschen C, Mohaupt M, et al. Nicotine strongly activates dendritic cell-mediated adaptive immunity. Circulation 2003; 107:604.
26. Lau PP, Lan L, Aksam JM, et al. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor -/- mice. Arterioscler Thromb Vasc Biol 2006; 26: 143.
27. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 1998; 84: 2089.
28. Macklin KD, Maus AD, Pereia EF, et al. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1998; 287: 435.
29. Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7: 27.
30. Heeschen C, Weis M, Aicher A, et al. A novel angiogeneic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002; 110: 527.
31. Conklin BS, Zhao W, Zhong DS, et al. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 2002; 160:4134.
32. Pilmore HL, Eris JM, Painter DM, et al. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 1999; 67: 929.
33. Lemstrom KB, Krebs R, Nykanen AI, et al. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 2002; 105: 2524.
34. Raisky O, Nykanen AI, Krebs R. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts. Arterioscler Thromb Vasc Biol 2007; 27:819.
35. Tambur AR, Pamboukian S, Costanzo MR, et al. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 2006; 25: 690.
36. Malmström NK, Kallio EA, Rintala JM, et al. Vascular endothelial growth factor in chronic rat allograft nephropathy. Transpl Immunol 2008; 19: 136.
37. Pfeil U, Lips KS, Eberling L, et al. Expression of the high-affinity choline transporter, CHT1, in the rat trachea. Am J Respir Cell Mol Biol 2003; 28: 473.
38. Pfeil U, Vollerthun R, Kummer W, et al. Expression of the cholinergic gene locus in the rat placenta. Histochem Cell Biol 2004; 122: 121.
39. Klapproth H, Reinheimer T, Metzen J, et al. Non-neuronal acetylcho-line, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 515.
40. Farlow MR. Update on rivastigmine. Neurologist 2003; 9: 230.
41. Massoulié J. The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 2002; 11: 130.
42. Scali C, Casamenti F, Bellucci A, et al. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. J Neural Transm 2002; 109: 1067.
43. Dijkstra CD, Döpp EA, Joling P, et al. The heterogeneity of mononu-clear phagocytes in lymphoid organs: Distinct macrophage subpopu-lations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589.
44. Li S, Zhao T, Xin H, et al. Nicotinic acetylcholine receptor alpha7 sub-unit mediates migration of vascular smooth muscle cells toward nicotine. J Pharmacol Sci 2004; 94: 334.
45. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007; 100: 967.
46. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol 2008; 154: 1558.
47. Schäfer MK, Eiden LE, Weihe E. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcho-line transporter. II. The peripheral nervous system. Neuroscience 1998; 84: 361.
48. Azuma H, Nadeau K, Takada M, et al. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997; 64: 190.
49. Torras J, Cruzado JM, Riera M, et al. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Kidney Int 1999; 56: 1798.
50. Fabre J, Lim SH, Morris PJ. Renal transplantation in the rat: Details of a technique. Aust N Z J Surg 1971; 41: 69.
51. Scriba A, Luciano L, Steiniger B. High-yield purification of rat mono-cytes by combined density gradient and immunomagnetic separation. J Immunol Methods 1996; 189: 203.
52. Reinheimer T, Bernedo P, Klapproth H. Acetylcholine in isolated airways of rat, guinea-pig, and humans: Species differences in the role of airway mucosa. Am J Physiol 1996; 270(5 pt 1): L722.